BMSC-Derived Exosomes Promote Retinal Ganglion Cell Survival

Share this content:
BMSC-Derived Exosomes Promote Retinal Ganglion Cell Survival
BMSC-Derived Exosomes Promote Retinal Ganglion Cell Survival

TUESDAY, Jan. 31, 2017 (HealthDay News) -- Bone marrow-derived mesenchymal stem cell (BMSC)-derived exosomes promote retinal ganglion cell (RGC) survival, according to a study published online Jan. 26 in Stem Cells Translational Medicine.

Noting that MSCs have demonstrated significant neuroprotective and axogenic effects on RGCs in optic neuropathy and glaucoma eye diseases, Ben Mead, Ph.D., and Stanislav Tomarev, Ph.D., from the National Institutes of Health in Bethesda, Md., isolated exosomes from BMSCs and tested them in a rat optic nerve crush (ONC) model.

The researchers demonstrated significant neuroprotective and neuritogenic effects with treatment of primary retinal cultures with BMSC exomes. Optical coherence tomography, electroretinography, and immunohistochemistry were performed 21 days after ONC and weekly intravitreal exosome injections. Statistically significant survival of RGCs was promoted by BMSC-derived exosomes and regeneration of their axons; in addition, there was partial prevention of RGC axonal loss and RGC dysfunction. The cargo of exosomes was delivered to inner retinal layers, and the effects were reliant on miRNA; after knockdown of Argonaute-2, a key miRNA effector molecule, the therapeutic effects of exosomes derived from BMSC were diminished.

"This study supports the use of BMSC-derived exosomes as a cell-free therapy for traumatic and degenerative ocular disease," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »